Alistair Macdonald - Aug 2, 2021 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Executive Officer, Director
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Aug 2, 2021
Transactions value $
-$2,030,451
Form type
4
Date filed
8/4/2021, 05:24 PM
Previous filing
Jun 3, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Sale -$423K -4.71K -2.35% $89.90 196K Aug 2, 2021 Direct F1
transaction SYNH Class A Common Stock Options Exercise $1.52M +35.6K +18.16% $42.76 231K Aug 3, 2021 Direct F1
transaction SYNH Class A Common Stock Sale -$2.5M -28.5K -12.33% $87.83 203K Aug 3, 2021 Direct F1, F2
transaction SYNH Class A Common Stock Sale -$622K -7.03K -3.47% $88.49 196K Aug 3, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -35.6K -100% $0.00* 0 Aug 3, 2021 Class A Common Stock 35.6K $42.76 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2020.
F2 The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $87.28 to $88.27, inclusive. The reporting person undertakes to provide Syneos Health, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $88.28 to $88.87, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares subject to this option vested in four approximately equal annual installments on August 1, 2017; August 1, 2018; August 1, 2019; and August 1, 2020.